Journal of Virology · 2013 · 52 citations · 25 references
Life SciencesImmunologyInfectious DiseasesImmunizationMolecular VirologyVirologyAntibody-antigen RecognitionAntibody-mediated ProtectionAntiviral ImmunityVaccines For Emerging PathogensViral GeneticsViral PathogenesisAntibodiesAntibody-mediated Viral NeutralizationCross-protective ImmunityCross-reactive AntigensCross-reactive ImmunityNewcastle Disease VaccinesViral Antigen Recognition
Severe human disease caused by the emerging H7N9 influenza virus in China warrants a rapid response. Here, we present a recombinant Newcastle disease virus expressing a North American lineage H7 influenza virus hemagglutinin. Sera from immunized mice were cross-reactive to a broad range of H7 subtype viruses and inhibited hemagglutination by the novel H7 hemagglutinin. Immunized mice were protected against a heterologous H7 subtype challenge, and genetic analysis suggested that cross-protective antibodies recognize conserved antigenic sites.
25
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Rongbao Gao, Bin Cao, Yunwen Hu et al. · New England Journal of Medicine · 2013 · 2.3K citations · Full text
Ron A. M. Fouchier, Peter M. Schneeberger, Frans W. Rozendaal et al. · Proceedings of the National Academy of Sciences · 2004 · 1.1K citations · Full text